Fas ligand is required for the development of respiratory syncytial virus vaccine-enhanced disease.

Olson, Matthew R

Fas ligand is required for the development of respiratory syncytial virus vaccine-enhanced disease. [electronic resource] - Journal of immunology (Baltimore, Md. : 1950) Mar 2009 - 3024-31 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural

1550-6606

10.4049/jimmunol.0803585 doi


Adjuvants, Immunologic--administration & dosage
Animals
Autoimmune Diseases--genetics
CD4-Positive T-Lymphocytes--immunology
CD8-Positive T-Lymphocytes--immunology
Cell Differentiation--genetics
Epitopes, T-Lymphocyte--immunology
Fas Ligand Protein--biosynthesis
Humans
Immunization, Secondary
Immunologic Memory--genetics
Lymphatic Diseases--genetics
Mice
Mice, Inbred BALB C
Mice, Mutant Strains
Pulmonary Eosinophilia--genetics
Respiratory Syncytial Virus Vaccines--administration & dosage
Respiratory Syncytial Viruses--immunology
Viral Envelope Proteins--administration & dosage